ecoli-uk.com

E.coli O157 & Haemolytic Uraemic Syndrome


HUSH supports application for feasibility study of the drug Eculizumab

5th October 2014

HUSH has supported an application for a feasibility study of the drug Eculizumab, for HUS sufferers.

The drug is currently being successfully used for sufferers of a similar illness called aHUS.

This application is supported by medical and public health experts who believe that this drug could be helpful for sufferers of HUS.

The funding application for this study to the National Institute of Health Research is at a very early stage of the process.

The application is lead by Dr Sally Johnson a Consultant Paediatric Nephrologist at Great North Children's Hospital Newcastle and is supported by Paediatric Nephrologists in England, Wales & Scotland.

If the feasibility application & study is successful it is hoped that a trial of the drug will be carried out on HUS sufferers.




Page
1 of 49
Next > Last >>

14th February 2025

At any price point, the food you purchase should be safe whatever your dietary requirements are. However foodborne illness is estimated to cost 10.4 billion pounds annually in the UK by government. ... ...read on
22nd December 2024

UK Health Security Agency  By email  ste... ...read on
5th November 2024

This Freedom of information request is in relation to the publication date for an outbreak report of E.coli O157 in 2022, where there was 259 reported cases from consuming salad products. ... ...read on
8th October 2024

By email  steve@ecoli-uk.com ... ...read on
9th September 2024

As you are aware, this matter relates to a complaint to the ICO with regard to the UKHSA’s failure to respond to my request for information, made under FOIA, dated 1st July 2024. ... ...read on
Page
1 of 49
Next > Last >>

Designed by Robert Woods. View our Cookie & Privacy Policy